Cookies help us to understand how you use our website so that we can provide you with the best experience when you are on our site. To find out more, read our privacy policy and cookie policy.
Manage Cookies
A cookie is information stored on your computer by a website you visit. Cookies often store your settings for a website, such as your preferred language or location. This allows the site to present you with information customized to fit your needs. As per the GDPR law, companies need to get your explicit approval to collect your data. Some of these cookies are ‘strictly necessary’ to provide the basic functions of the website and can not be turned off, while others if present, have the option of being turned off. Learn more about our Privacy and Cookie policies. These can be managed also from our cookie policy page.
Strictly necessary cookies(always on):
Necessary for enabling core functionality. The website cannot function properly without these cookies. This cannot be turned off. e.g. Sign in, Language
Analytics cookies:
Analytical cookies help us to analyse user behaviour, mainly to see if the users are able to find and act on things that they are looking for. They allow us to recognise and count the number of visitors and to see how visitors move around our website when they are using it. Tools used: Google Analytics
Social media cookies:
We use social media cookies from Facebook, Twitter and Google to run Widgets, Embed Videos, Posts, Comments and to fetch profile information.
Supporting women recently diagnosed with breast cancer taking part in research
Share Supporting women recently diagnosed with breast cancer taking part in research on FacebookShare Supporting women recently diagnosed with breast cancer taking part in research on TwitterShare Supporting women recently diagnosed with breast cancer taking part in research on LinkedinEmail Supporting women recently diagnosed with breast cancer taking part in research link
This project has now completed. Thank you to everyone who contributed ideas for making a short film.
Your views on the content of a short video for patients taking part in the POETIC-A trial.
The purpose of the video is to support women taking part in a clinical trial called POETIC-A, who may experience diarrhoea as a result of taking a drug called abemaciclib. We would like to hear from you about our proposed content and style of the video. This will help us to make improvements and to make sure that what matters most to patients is included in the video.
The short questionnairebelow should take about 10 minutes to complete..
What is the POETIC-A trial?
POETIC-A (Pre-Operative Endocrine Therapy for Individualised Care with Abemaciclib) is a new trial for women recently diagnosed with early breast cancer. The trial is sponsored by The Institute of Cancer Research and launched in December 2020. POETIC-A is aiming to recruit more than 5000 patients across the UK.
Women taking part in the POETIC-A trial will receive either i) standard anti-hormone treatment alone or ii) a new drug called abemaciclib plus anti-hormone treatment.
Abemaciclib is a tablet taken daily for two years at the same time as standard anti hormone therapy.
It is very important that patients taking part in POETIC-A remain on abemaciclib for the full duration of treatment. However, one of the known side effects of abemaciclib is diarrhoea.
Therefore, we are designing a video to support patients during their treatment and between follow-up appointments.
Are you interested in helping us with the next stage of video production?
We would like to invite 4-5 patient representatives to join a focus group to contribute to the design and editing of the video.
More details can be found at the end of the questionnaire, where you can register your interest. Participants in the focus group will be reimbursed for their contribution.
This POETIC-A trial is funded byEli Lilly and Companyand Cancer Research UK. The production of this video is funded by the National Institute for Health Research (NIHR) Biomedical Research Centre (BRC) at The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research.
Your views on the content of a short video for patients taking part in the POETIC-A trial.
The purpose of the video is to support women taking part in a clinical trial called POETIC-A, who may experience diarrhoea as a result of taking a drug called abemaciclib. We would like to hear from you about our proposed content and style of the video. This will help us to make improvements and to make sure that what matters most to patients is included in the video.
The short questionnairebelow should take about 10 minutes to complete..
What is the POETIC-A trial?
POETIC-A (Pre-Operative Endocrine Therapy for Individualised Care with Abemaciclib) is a new trial for women recently diagnosed with early breast cancer. The trial is sponsored by The Institute of Cancer Research and launched in December 2020. POETIC-A is aiming to recruit more than 5000 patients across the UK.
Women taking part in the POETIC-A trial will receive either i) standard anti-hormone treatment alone or ii) a new drug called abemaciclib plus anti-hormone treatment.
Abemaciclib is a tablet taken daily for two years at the same time as standard anti hormone therapy.
It is very important that patients taking part in POETIC-A remain on abemaciclib for the full duration of treatment. However, one of the known side effects of abemaciclib is diarrhoea.
Therefore, we are designing a video to support patients during their treatment and between follow-up appointments.
Are you interested in helping us with the next stage of video production?
We would like to invite 4-5 patient representatives to join a focus group to contribute to the design and editing of the video.
More details can be found at the end of the questionnaire, where you can register your interest. Participants in the focus group will be reimbursed for their contribution.
This POETIC-A trial is funded byEli Lilly and Companyand Cancer Research UK. The production of this video is funded by the National Institute for Health Research (NIHR) Biomedical Research Centre (BRC) at The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research.
The purpose of this questionnaire is to ask for your views on the style and content of a video designed to support women who may experience diarrhoea as a result of taking abemaciclib as part of the POETIC-A trial .
If you would like to add any comments or suggestions about the contents of the video please enter these in the box provided at the end of the questionnaire.
This project has now completed. Thank you to everyone who contributed ideas for making a short film.
Share We are asking for your views on the content of a short video for patients taking part in the POETIC-A trial. on FacebookShare We are asking for your views on the content of a short video for patients taking part in the POETIC-A trial. on TwitterShare We are asking for your views on the content of a short video for patients taking part in the POETIC-A trial. on LinkedinEmail We are asking for your views on the content of a short video for patients taking part in the POETIC-A trial. link
